FIG 11
In vivo analysis of TRα target genes. (A and B) Expression of thyroid hormone receptor target genes (KLF9 and Dio3b) in WT and E403X mutant TRα-injected zygotes exposed to vehicle (DMSO), T3, or ES08. Results are expressed as fold changes versus DMSO-treated cells. *, P < 0.05; **, P < 0.01 for comparison with vehicle-treated embryos. (C) Expression KLF9 (a thyroid hormone receptor target gene) in inducible pluripotent stem cells derived from patient harboring an E403X TRα mutation, with increasing concentrations of T3 or ES08 analogue. Results are expressed as fold changes versus nontreated cells: *, P < 0.05; **, P < 0.01 for comparison of E403X with T3 versus E403X with ES08. |